Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population
- PMID: 26209836
- PMCID: PMC4547875
- DOI: 10.1016/j.vaccine.2015.07.037
Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population
Abstract
Background: The Vaccine Safety Datalink (VSD) is a collaboration between CDC and nine integrated health care systems that serves as a cornerstone of US post-licensure vaccine safety monitoring. Given concerns that potential differences between the insured VSD population and the US population could limit the generalizability of VSD study findings, we performed a comparison of the demographic characteristics between the two populations.
Methods: We collected data from medical records and administrative files at VSD sites in 2010 to compare sex, age, race, ethnicity, income, and educational attainment to the 2010 US Census population. We also compared data on the 2012 VSD Medicaid population to 2012 US Medicaid data.
Results: The VSD population included over eight million individuals in 2010, which represented 2.6% of the total US population. All major demographic groups were represented in the VSD. We found no major differences in comparing sex, race, ethnicity, and educational attainment between the VSD and the US population. Middle income populations were comparable between the VSD and the US. While the percentage of lower income populations was less in the VSD compared to the US, the VSD had over two million individuals in this group. Additionally, there were over 600,000 Medicaid members in the VSD in 2012, which represented 1.1% of the US Medicaid population.
Conclusions: We found that the VSD population is representative of the general US population on several key demographic and socioeconomic variables. Despite a few specific groups being underrepresented in the VSD compared to the US, the absolute number of VSD members is large enough to ensure significant representation of these groups in vaccine safety studies that use VSD data.
Keywords: Census; Demographics; Medicaid; Vaccine Safety Datalink.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Vaccine adverse events in a safety net healthcare system and a managed care organization.Vaccine. 2017 Mar 1;35(9):1335-1340. doi: 10.1016/j.vaccine.2017.01.017. Epub 2017 Feb 6. Vaccine. 2017. PMID: 28185740 Free PMC article.
-
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6. Vaccine. 2014. PMID: 25108215 Free PMC article. Review.
-
The Vaccine Safety Datalink: a model for monitoring immunization safety.Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502240 Review.
-
The Vaccine Safety Datalink project.Pharmacoepidemiol Drug Saf. 2001 Aug-Sep;10(5):403-6. doi: 10.1002/pds.613. Pharmacoepidemiol Drug Saf. 2001. PMID: 11802585
-
Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).J Clin Epidemiol. 1998 Jun;51(6):503-10. doi: 10.1016/s0895-4356(98)00014-6. J Clin Epidemiol. 1998. PMID: 9635999
Cited by
-
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection.Nat Commun. 2024 May 22;15(1):4101. doi: 10.1038/s41467-024-48022-9. Nat Commun. 2024. PMID: 38778026 Free PMC article.
-
Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals.JAMA Netw Open. 2024 Apr 1;7(4):e245479. doi: 10.1001/jamanetworkopen.2024.5479. JAMA Netw Open. 2024. PMID: 38587844 Free PMC article.
-
Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes.Prev Med. 2023 Dec;177:107751. doi: 10.1016/j.ypmed.2023.107751. Epub 2023 Nov 4. Prev Med. 2023. PMID: 37926397 Free PMC article.
-
Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons.Vaccine. 2023 Nov 22;41(48):7138-7146. doi: 10.1016/j.vaccine.2023.10.023. Epub 2023 Oct 20. Vaccine. 2023. PMID: 37866991 Free PMC article.
-
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines.Vaccine. 2023 Sep 7;41(39):5678-5682. doi: 10.1016/j.vaccine.2023.08.023. Epub 2023 Aug 19. Vaccine. 2023. PMID: 37599140
References
-
- Roush SW, Murphy TV Vaccine-Preventable Disease Table Working G. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. Jama. 2007;298:2155–2163. - PubMed
-
- Cooper LZ, Larson HJ, Katz SL. Protecting public trust in immunization. Pediatrics. 2008;122:149–153. - PubMed
-
- Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011;127(Suppl 1):S45–S53. - PubMed
-
- Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. The New England journal of medicine. 2014;370:513–519. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical